WP only refers to the company as a Structural Heart Company. I believe the mitral repair interest will be our next exciting area. At the time of the AGM they only had 30 percent of the venture. I would like them to get to 80 percent. No doubt we might be creeping up if we are supplying expensive engineering knowhow. That does not come cheap . If it proves disruptive perhaps they could sell it off to fund the pivotal trial. Or sell the TAVR business and keep the mitral.
Further Update on Edwards, page-201
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 312 | $15.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 626 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |